SOPHiA GENETICS
SOPH
SOPH
34 hedge funds and large institutions have $80.2M invested in SOPHiA GENETICS in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $90.9M → $80.2M (-$10.8M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.77M | |
| 2 | +$461K | |
| 3 | +$69.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.18K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.07M | |
| 3 | -$309K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$287K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$92.3K |